Concepedia

Publication | Open Access

Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study

DOIFull Paper Access

220

Citations

26

References

2011

Year

John de Groot, Kathleen R. Lamborn, Susan M. Chang, Mark R. Gilbert, Timothy F. Cloughesy, Kenneth Aldape, Jun Yao, Edward F. Jackson, Frank S. Lieberman, H. Ian Robins,
Journal of Clinical Oncology

Abstract

Aflibercept monotherapy has moderate toxicity and minimal evidence of single-agent activity in unselected patients with recurrent malignant glioma.

References

YearCitations

Page 1